ANGRP Inhibitors
ANGRP inhibitors are a class of chemical compounds designed to target and inhibit the activity of the protein known as angio-associated migratory cell protein (ANGRP). ANGRP is involved in cellular processes such as cell migration and angiogenesis, the formation of new blood vessels. By inhibiting ANGRP, these compounds interfere with the protein's role in regulating cellular motility and vascular development. ANGRP inhibitors typically work by binding to the protein or its interaction partners, blocking the pathways that drive cell movement or vascular formation. These inhibitors are valuable tools for studying how ANGRP influences cellular behavior and understanding its role in complex biological systems like tissue development and repair.
The development of ANGRP inhibitors involves detailed structural and functional studies of the protein. Techniques such as X-ray crystallography, molecular dynamics simulations, and protein-protein interaction assays are used to identify critical domains and binding sites on ANGRP. With this knowledge, researchers design inhibitors that selectively target these sites, preventing ANGRP from interacting with other molecules or from participating in signaling pathways related to cell migration and angiogenesis. The specificity of ANGRP inhibitors is essential for ensuring they precisely disrupt the function of this protein without affecting related proteins or other cellular processes. These inhibitors are often engineered as small molecules or peptide-based compounds, designed to mimic natural substrates or binding partners of ANGRP. By selectively modulating ANGRP activity, these inhibitors provide insights into the molecular mechanisms governing cell migration and angiogenesis, contributing to a broader understanding of how these processes are regulated at the cellular and molecular levels.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates into DNA, obstructing the transcription process and could lead to decreased ANGRP mRNA synthesis by preventing its gene transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate, a polyphenol found in green tea, may inhibit several key enzymes involved in the biosynthesis of nucleotides, potentially leading to a reduction in the overall pool of nucleotides available for ANGRP gene transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting mTOR, a central cell-growth regulator, rapamycin could suppress the translation of ANGRP mRNA into the angiogenin protein, thereby reducing its expression. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
As an EGFR tyrosine kinase inhibitor, erlotinib may downregulate ANGRP by hindering the EGFR signaling pathway, which is often involved in promoting angiogenesis and associated gene expression. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin may decrease ANGRP expression by inhibiting the mevalonate pathway, which is essential for the synthesis of cholesterol and isoprenoid compounds that can be crucial for cell membrane integrity and signaling functions related to gene expression. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A might suppress ANGRP by inhibiting the activity of calcineurin, leading to reduced dephosphorylation and activation of the transcription factor NFAT, which may be necessary for ANGRP gene expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
This inhibitor of c-Jun N-terminal kinase (JNK) may reduce ANGRP expression by preventing the activation of transcription factors that bind to the ANGRP gene promoter region, thereby suppressing its transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 inhibits PI3K, possibly leading to the downregulation of ANGRP by blocking the Akt signaling pathway, which can be crucial for cell survival and angiogenesis-related gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, 5-Azacytidine could decrease ANGRP expression by causing hypomethylation of DNA, which can lead to the suppression of gene expression through epigenetic modifications. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram may inhibit the expression of ANGRP through its metal ion chelation properties, particularly copper, which is a cofactor for enzymes that could be involved in the angiogenesis process where ANGRP plays a role. | ||||||